Anthropic's stock popped on its Nasdaq debut this week, and that is the least interesting part of the story. The real news in Anthropic's IPO is what public shareholders agreed to buy: a stake in a company where one class of stock, held by seven people, controls the vote no matter how many shares anyone else owns.
Key takeaways
- Anthropic priced its IPO at $83 a share, above the original $70 to $78 range, and began trading on the Nasdaq Global Select Market on November 19, 2026 under the ticker ANT, according to Nasdaq's own listing notice.
- A single Class F share held by Anthropic's seven co-founders carries a fixed 50.1% of the shareholder vote, capping every other shareholder, including every IPO buyer, at a combined 49.9%, according to the S-1 as reported by The Motley Fool.
- The company reported a $104 billion net loss for the nine months ended September 30, 2026, on $33.24 billion in revenue, a figure driven largely by non-cash accounting charges rather than operating costs, according to the prospectus as reported by CNBC.
- Anthropic's Long-Term Benefit Trust, designed to hold five trustees, can elect and remove four of the company's seven board directors, but corporate governance expert Nell Minow called the arrangement "the most bananas corporate governance structure in history" because it sets no clear legal standard for what the company owes shareholders.
What Actually Priced on Nasdaq This Week
The mechanics are straightforward. Anthropic's bankers marketed the Anthropic IPO at $70 to $78 a share, then closed the order book above that range and priced the deal at $83, according to Nasdaq's official listing notice. Trading opened on the Nasdaq Global Select Market under the ticker ANT on November 19, with the stock registered as Anthropic, PBC Class A common stock.
That order-book demand is the headline most coverage led with, and it is a real signal: institutional buyers wanted more stock than the company was willing to sell at the top of its range. But a priced-above-range IPO only tells you that short-term demand exceeded supply at that price. It says nothing about what those buyers actually gained control over, which is where this story gets more useful.
The Losses Are a Symptom of Growth, Not a Warning Sign
Anthropic's income statement looks alarming at first glance. For the nine months ended September 30, 2026, the company reported revenue of $33.24 billion, up roughly 1,200% year over year, alongside a net loss of $104 billion, according to the prospectus as reported by CNBC. Earlier in the year, six-month 2026 revenue was $16.3 billion against $1.2 billion a year earlier, with a $80.7 billion net loss that included a $72.4 billion non-cash fair-value charge, according to a filing analysis from SEC-API.io.
That gap between revenue and loss is not Anthropic burning cash at an unsustainable rate. It is an accounting artifact of convertible notes and derivative instruments that get revalued to match the company's soaring private-market price before conversion. The better Anthropic's underlying business looked to investors, the bigger its paper loss grew, because the notes it issued earlier were converting at a much higher implied valuation. Readers should not confuse this mechanical effect with operating losses from running the business.
Anthropic's debut also lands inside a much bigger spending wave. The four largest hyperscalers, Microsoft, Alphabet, Amazon and Meta, are on track to spend roughly $700 billion to $750 billion combined on capital expenditure in 2026, up from about $410 billion in 2025, according to multiple analyst compilations of company guidance. Anthropic does not build its own data centers at that scale, but it depends on cloud capacity from exactly these companies, so the AI industry's capital intensity is the backdrop against which its own numbers have to be read.
One Share, 50.1% of the Vote, No Dividends Attached
Here is the part of the filing that matters more than the opening trade. Anthropic's seven co-founders hold a Class F share that carries a fixed 50.1% of the vote on ordinary shareholder matters, with a majority of the founders deciding how that single share votes, according to the S-1 as summarized by The Motley Fool. Every other shareholder, public and private combined, is capped at a 49.9% voting bloc regardless of how much stock they hold. The same reporting notes that Class F carries no economic rights: it pays no dividends and has no claim on profits, so its entire purpose is control, not ownership.
That structure is not unique to Anthropic. Founder-controlled dual-class stock has been standard at tech IPOs since Google went public with a similar setup in 2004. What is unusual here is the scale of the number attached to it: investors bought into a roughly $100 billion-revenue-run-rate company knowing in advance that no combination of outside shareholders, however large, can ever outvote seven people on anything the Class F share covers.

The Trust That Can Lose Its Own Teeth
Anthropic has long described its Long-Term Benefit Trust as the mechanism that keeps the company's safety mission accountable to something other than shareholder returns. The company's own description says the trust is designed to hold five independent trustees. Several independent analyses of the S-1, including coverage from Puck and a filing breakdown published by FourWeekMBA, say the trust can elect and remove four of Anthropic's seven board directors.
Never miss a story
Tools, tutorials and AI deep-dives - straight to your inbox, every week.
Nell Minow, vice-chair of ValueEdge Advisors and a longtime corporate governance critic, told Puck the arrangement is "the most bananas corporate governance structure in history" and "an absolute mess," arguing that the filing sets "no legal standard about what they owe shareholders." Her objection is not that founders keep control, plenty of IPOs do that, but that the trust's authority and the standard it is supposed to enforce are not clearly defined anywhere investors can point to and hold the company accountable.
There is a second wrinkle worth flagging honestly: the trust is not permanently bulletproof either. Legal analysis circulated around the filing, including a piece published through Harvard Law School's Forum on Corporate Governance, has noted that a supermajority of Anthropic's investors can vote to terminate the trust and remove the directors it appointed, a provision reported but not yet tested in practice. So the arrangement cuts both ways: public shareholders have almost no routine influence, but they are not locked out of changing the structure forever if enough of them ever agreed to try.

The Honest Counterargument: This Might Be the Least-Bad Option
The strongest case for Anthropic's structure is the one its critics usually skip. A standard public company board answers to whichever shareholders show up at the annual meeting, and that board can be pressured, quarter by quarter, to deprioritize safety testing, red-teaming and model-release delays in favor of faster shipping and bigger buybacks. Anthropic's leadership has argued, consistent with its earlier public stance on coordinated AI slowdowns, that a board insulated from short-term shareholder pressure is exactly what lets a frontier AI lab keep safety commitments when they conflict with revenue growth.
That argument is not unreasonable. OpenAI's own capped-profit, nonprofit-controlled structure drew the same category of criticism for years, that it was vague, hard to enforce and ultimately subordinate to commercial pressure once real money was at stake. Minow's critique is really a narrower one: not that insulating a board from shareholders is wrong in principle, but that Anthropic's filing never specifies the standard the trust is supposed to enforce, so there is no way for an outside party to prove the trust failed at its job even if it did. A vague mandate that nobody can hold anyone accountable to is a legitimate flaw, even if the underlying goal of the mandate is sound.

Who Should Buy This, Who Should Skip It, and What to Watch
Treat ANT as a bet on enterprise AI demand growth, not as a bet on influencing how the company is run. That distinction should drive the decision.
- Buy it if you want direct exposure to Anthropic's revenue growth and enterprise AI adoption, and you are comfortable owning stock with zero practical voting leverage over product, safety or capital-allocation decisions.
- Skip it if your investment thesis depends on shareholder pressure eventually forcing governance changes, or if you need a holding that behaves like a normal industrial company with standard proxy-vote accountability.
- Watch the next few quarterly filings for the ratio of operating cash flow to the non-cash fair-value swings, since that ratio, not the headline net-loss number, is the real test of whether the business is healthy.
- Watch whether any investor coalition ever tests the supermajority provision to challenge the Long-Term Benefit Trust, since that would be the first real evidence of whether public shareholders have any practical leverage at all.
This matters most to people who already hold Anthropic equity through employee grants, to institutional investors building AI-sector exposure, and to anyone tracking how AI labs structure governance as they approach public markets, including those watching for a similar move from Anthropic's closest competitors. It matters less to someone looking for a short-term trading signal, since a single priced-above-range debut says little about where the stock settles once the lockup period and first full earnings cycle pass.
The concrete takeaway: Anthropic's IPO did not transfer meaningful control to the public markets, and it was never supposed to. The company sold economic participation while keeping governance locked down by design. That is a legitimate structure for a company that believes short-term shareholder pressure is dangerous for how it operates, but it is also a structure investors should price in explicitly, rather than discovering the hard way the first time a safety decision costs the stock money and nobody with a vote has to answer for it.
Sources
- Nasdaq Trader News: Anthropic, PBC listing notice
- CNBC: Anthropic likely to price IPO above range
- SEC-API.io: Anthropic (ANT) S-1 IPO filing analysis
- Citywire: What Anthropic's S-1 reveals
- The Motley Fool: Anthropic's IPO keeps founders in control
- Anthropic: The Long-Term Benefit Trust
- Puck: Will Anthropic's IPO leave shareholders holding the bag
- FourWeekMBA: Anthropic's IPO filing shows how its trust could lose power
- FourWeekMBA: Meta, Google, Amazon, Microsoft near $750B of 2026 capex